Bilibili urged to rectify e-cigarette content

Jul.26.2022
Bilibili urged to rectify e-cigarette content
Shanghai prosecutors urge Bilibili to reform e-cigarette information to protect minors amid widespread use among youth.

The Yangpu District People's Procuratorate in Shanghai has urged Bilibili to rectify its dissemination of electronic cigarette information on its online platform.


Recently, the Yangpu District People's Procuratorate in Shanghai, during routine inspections, discovered that certain electronic cigarette-themed videos on the Bilibili platform may pose a risk of enticing minors to use electronic cigarettes during the process of being published and disseminated.


After rectification, all e-cigarette themed videos on the Bilibili platform now have significant warnings against underage use of e-cigarettes. Additionally, the platform has optimized its search system and correctly guides against underage consumption of e-cigarettes and pods when such keywords are searched.


User portrait of Bilibili.


Bilibili is a unique and scarce PUGC (Professional User Generated Content) video community and a leader in the PUGC video industry. Unlike short-form videos, PUGC video creation requires a higher level of skill and provides more robust content. According to statistics from Ping An Securities, in 2020, Bilibili had 2.2 million creators uploading 7.7 million videos, generating 6.6 billion interactions every month.


In October 2020, the Chairman of Bilibili, Chen Rui, stated at the 8th China Internet Audiovisual Conference, "Bilibili users are the youngest group among Chinese Internet users. From 2015 to 2020, the number of Bilibili users increased by 10 times. In the first quarter of 2020, the number of monthly active Bilibili users reached 172 million, of which 78% were young people aged between 18 and 35." It is estimated that more than 50% of young urban netizens and over 80% of middle and high school students and college students in first and second-tier cities are Bilibili users. These user groups have a strong willingness to pay.


Therefore, some e-cigarette retailers have targeted Bilibili, a platform with a large, young, and vibrant user base, for marketing. Bilibili is constantly featuring e-cigarette product reviews and new product promotions. Due to its search mechanism, it is currently impossible to determine the total number of e-cigarette-related videos posted on Bilibili, but it can be observed that approximately 50 such videos are uploaded daily.


The Bilibili platform utilizes the keyword search term "electronic cigarettes" to generate search results.


The Number of Chinese Adolescents Using E-Cigarettes


On May 29, 2022, the Chinese Center for Disease Control and Prevention released the "2021 Tobacco Use Among Middle and High School Students and College Students in China" monitoring report. The survey covered 136,296 middle school students, 132,954 high school students, and 124,119 college students from 31 provinces (regions, municipalities) across the country. According to the survey, electronic cigarettes are widely popular among young people.


In 2021, 86.6% of secondary school students have heard of e-cigarettes, with 16.1% having used them. 3.6% of secondary school students are currently using e-cigarettes. The most commonly used e-cigarette flavor among 63.8% of secondary school students is fruit flavor.


In 2021, 90.3% of college students have heard of e-cigarettes. The proportion of students who have used e-cigarettes is 10.1%, and the current usage rate is 2.5%, both higher than the results of the 2018 National Adult Tobacco Survey. The proportion of male students currently using e-cigarettes (3.9%) is higher than that of female students (1.1%), and students in vocational colleges (3.3%) have a higher usage rate than those in provincial and state-owned colleges (1.9%) and joint colleges (1.3%).


Screenshot of the official website of the Chinese Center for Disease Control and Prevention.


Reasons for Teenage Smoking Ban and Related Regulations.


On January 11, 2021, Dr. John Pierce, a Professor of Public Health at the University of California, San Diego, and his team published a study in Pediatrics on the relationship between teenage e-cigarette use and daily tobacco use, finding that e-cigarette use directly leads to future tobacco addiction among adolescents. Students who have only used e-cigarettes 1-2 times are 2.88 times more likely to smoke traditional cigarettes one year later compared to those who have never smoked. The study shows that underage nicotine exposure can have an impact on attention, learning, emotional fluctuations, and impulse control. Long-term use can also have adverse effects on brain development, resulting in learning disabilities, anxiety disorders, and other illnesses, severely impacting both physical and mental health.


This study is consistent with previous findings in the public health field: teenagers with strong curiosity are more prone to become dependent on nicotine without fully understanding the health risks, which may lead to becoming long-term smokers.


According to relevant provisions of the Law on the Protection of Minors, the Notice on Prohibiting the Sale of Electronic Cigarettes to Minors, and the Notice on Further Protecting Minors from Electronic Cigarette Harm, all types of market entities are prohibited from selling or promoting electronic cigarettes to minors. The media and other sectors of society should actively promote and guide the public to protect minors from the harm of electronic cigarettes.


On May 1, 2022, the "Regulations on Electronic Cigarette Management" were promulgated. According to Article 6, "The state and society should strengthen publicity and education on the harmful effects of electronic cigarettes, discourage adolescents from smoking electronic cigarettes, and prohibit primary and secondary school students from smoking electronic cigarettes." Article 18 states: “Special education schools, secondary vocational schools, special schools, and kindergartens cannot set up electronic cigarette product sales outlets around them.” Article 22 states: “It is prohibited to sell electronic cigarette products to minors. Electronic cigarette operators should set up signs in prominent locations indicating that they do not sell electronic cigarettes to minors. If it is difficult to determine whether the customer is a minor, they should be asked to show their identification documents.”


As the popularity of electronic cigarettes continues to rise, an increasing number of public health experts are calling on the government to intervene early to curb the trend of teenagers using e-cigarettes and potentially becoming addicted to tobacco.


This article is an original creation of Shenzhen 2FIRSTS Technology Co., Ltd. The copyright and permission to use belong to the company. Without authorization, no unit or individual may copy, reprint, or use other means to infringe upon the company's copyright. The company reserves the right to pursue legal responsibility for any violations.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
FDA Authorizes 24 VELO Nicotine Pouches, Increasing U.S. Authorized Total by 56%
The U.S. FDA authorized 24 VELO nicotine pouch products from a British American Tobacco subsidiary, raising the total number of authorized products from 43 to 67, a 55.8% increase. The newly authorized 4 mg products include lime and passion fruit flavors and feature certified child-resistant packaging. VELO's first FDA marketing authorization adds BAT to a list previously limited to PMI and Altria products, while bringing the agency's nicotine pouch review pilot total to 47 authorized products.
Oct.30
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Q3 Sales Rise 11%, but New Products Generate Just $2.1 Million in Nine Months as U.S. Vape Push Awaits FDA Review
AIR Global PLC (NASDAQ: AIIR), a producer of flavored shisha tobacco and next-generation nicotine products, reported an 11.1% increase in third-quarter 2026 revenue to $99.8 million and a 7.7% rise in adjusted EBITDA to $30.9 million. Revenue for the first nine months increased 6.0% to $306.7 million, but the company posted a $74.2 million net loss, affected by listing-related expenses and other costs. Its New Growth Categories (NGC) business generated $2.1 million in nine-month revenue and an adjusted EBITDA loss of $10.8 million. AIR maintained its 2026 revenue growth guidance of 4%–6%, while lowering its capital expenditure outlook and raising its year-end leverage forecast from approximately 2.1 times to 2.5 times. The company has submitted a U.S. PMTA for its Crown Switch pod vape, with future contributions from new products dependent on regulatory progress and commercialization.
Capital Markets
Nov.13
Philip Morris Loses Two European Nicotine Pouch Patents in a Month Following BAT Challenges Over Nicotine Release and Formulation Technology
Philip Morris Loses Two European Nicotine Pouch Patents in a Month Following BAT Challenges Over Nicotine Release and Formulation Technology
The European Patent Office (EPO) published an appeal decision on November 17, 2026, revoking Philip Morris Products S.A.'s European nicotine pouch patent EP 3773494, covering a formulation involving free-base nicotine, ion-exchange resin and a water content of at least 15%. The decision followed an opposition and appeal brought by British American Tobacco (BAT) entity Nicoventures Trading Limited. Philip Morris withdrew its approval of the patent text during the appeal, leading the EPO to revoke the patent. A separate European patent, EP 3809884, covering the distribution of nicotine between a pouch membrane and its internal composition, had been revoked on September 24 following a challenge from another BAT entity. The patents share a 2019 priority basis, while related European divisional applications also exist.
company
Nov.18 by 2Firsts Perspectives